… the vast majority of thyroid cancer patients, have … times, we will hopefully be able to offer
more vigilant surveillance for the small (but by no means negligible) subset of thyroid cancer …

… cancers, but limited data exist for well-differentiated thyroid cancer. We sought to investigate
the impact of time to surgery on overall survival in patients with papillary thyroid cancer. …

… thyroid cancer (WDTC), investigation of the clinical course leading to death is limited. We
analyzed the cause of death and clinical course … clinical course; that is, inoperable at the time of …

… of thyroid cancer nodules (9–13%) as increasing during observation. These findings
support the use of either the well-established >3 mm increase in size, or the recently validated …

… trilogy revealed the existence of self-limiting cancer for the first time in human history. For
the past several decades, researchers and clinicians have considered that cancers undergo …

… Thyroid cancer is the fifth most common cancer in women in … thyroid cancer is the most
frequent subtype of thyroid cancer … At the same time, they need to recognise those patients with …

… Thyroid Association guidelines for the management of thyroid nodules and differentiated
thyroid cancer … in RAI refractory follicular cell–derived thyroid cancer (FCDTC) patients with …

… Four types of thyroid cancer comprise more than 98% of all thyroid malignancies. Papillary
thyroid carcinoma (PTC) may have a very benign course while undifferentiated thyroid …

… differentiated thyroid cancer) was the most important … % for differentiated thyroid cancer and
medullary thyroid cancer, respectively. … thyroid cancer and medullary thyroid cancer patients. …

… in the management of differentiated thyroid cancer (DTC) … iodine (radioiodine), thyroid
hormone treatment and availability … Patients with low-risk DTC, in whom the risk of thyroid cancer …